Results 21 to 30 of about 45,210 (266)

Early hypersalivation as a risk marker for inflammatory adverse reactions to clozapine. [PDF]

open access: yesPCN Rep
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Miyahara K, Ishida T, Ino H, Nunomura A.
europepmc   +2 more sources

Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study

open access: yesBMC Psychiatry, 2022
Objective Clozapine may cause serious side effects despite benefits in patients with schizophrenia. Thus, an accurate understanding of the side-effect profile of clozapine is extremely important in the management of its administration to patients with ...
Yuta Kawakita   +6 more
doaj   +1 more source

Clozapine prescribing during follow-up of a first-episode psychosis cohort

open access: yesEuropean Psychiatry, 2021
Introduction Of those with schizophrenia, one third develop treatment-resistant illness. Nearly 60% of these benefit from clozapine- the only antipsychotic medication licensed in this group.
R. Rowntree   +7 more
doaj   +1 more source

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]

open access: yes, 2002
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Hummel, B.   +5 more
core   +1 more source

Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors. [PDF]

open access: yes, 2009
The widely used atypical antipsychotic clozapine is a potent competitive antagonist at 5-HT(3) receptors which may contribute to its unique psychopharmacological profile. Clozapine binds to 5-HT(3) receptors of various species.
Gerhard Rammes   +28 more
core   +2 more sources

How Non-Medical Prescribing may Impact on the Service Development of a Clozapine Clinic [PDF]

open access: yes, 2009
The purpose of this article is to discuss the possible implications of applying non medical prescribing practices to a Clozapine clinic in the Rotherham, Doncaster and South Humber Mental Health NHS Foundation Trust (RDASH). To reflect on such issues the
Woolhouse, Nicola
core   +2 more sources

Clozapine and smoking [PDF]

open access: yes, 2016
This is a small case study on a patient on clozapine and it's absence on the pharmacy medication record, healthy living advice and a question on smoking ...
Khan, Nahim
core   +2 more sources

sj-jpeg-1-tpp-10.1177_20451253211072341 – Supplemental material for Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study

open access: yes, 2022
Supplemental material, sj-jpeg-1-tpp-10.1177_20451253211072341 for Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study by Claas-Frederik Johannsen, Tonny Studsgaard Petersen, Jimmi Nielsen ...
Anders Fink-Jensen (724822)   +5 more
core   +1 more source

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation

open access: yesTherapeutic Advances in Psychopharmacology, 2020
Background: Clozapine formulation has been shown to affect plasma concentrations of clozapine and norclozapine. Changes in formulation might result in toxicity or treatment failure.
Farinaz Keshavarzi   +3 more
doaj   +1 more source

Factors predicting serum clozapine levels in Middle Eastern patients: an observational study

open access: yesBMC Psychiatry, 2022
Background Despite its superiority over other drugs for psychosis, clozapine remains underused and is associated with many clinical challenges, including difficulties in predicting therapeutic serum levels (350-600 ng/mL).
Ahmed Hassab Errasoul   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy